LCM Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $443K | Sell |
|
|||||
|
2025
Q2 | $457K | Buy |
|
|||||
|
2025
Q1 | $601K | Sell |
|
|||||
|
2024
Q4 | $561K | Buy |
|
|||||
|
2024
Q3 | $512K | Buy |
|
|||||
|
2024
Q2 | $409K | Buy |
|
|||||
|
2024
Q1 | $533K | Sell |
|
|||||
|
2023
Q4 | $510K | Sell |
|
|||||
|
2023
Q3 | $589K | Buy |
|
|||||
|
2023
Q2 | $642K | Buy |
|
|||||
|
2023
Q1 | $696K | Buy |
|
|||||
|
2022
Q4 | $705K | Buy |
|
|||||
|
2022
Q3 | $695K | Sell |
|
|||||
|
2022
Q2 | $755K | Sell |
|
|||||
|
2022
Q1 | $734K | Buy |
|
|||||
|
2021
Q4 | $623K | Buy |
|
|||||
|
2021
Q3 | $583K | Sell |
|
|||||
|
2021
Q2 | $669K | Sell |
|
|||||
|
2021
Q1 | $652K | Sell |
|
|||||
|
2020
Q4 | $677K | Buy |
|